Hope Starkman
Rheumatology · Lake Worth, FLNPI 1144216797
Payments from drug & device makers
Across 119 payments — averaging $27.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$870
- AbbVie$560
- Pfizer$363
- UCB, Inc.$319
- Amgen$216
- Radius Health, Inc.$114
- plus $787 from 16 others
What the payments were for
- Consulting fees$52516%
- Grants$2407%
- Food & beverage$2,44776%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $870 |
| AbbVie | 14 | $560 |
| Pfizer | 19 | $363 |
| UCB, Inc. | 17 | $319 |
| Amgen | 11 | $216 |
| Radius Health, Inc. | 5 | $114 |
| Boehringer Ingelheim | 4 | $111 |
| Mallinckrodt Enterprises LLC | 5 | $92 |
| GSK | 3 | $81 |
| Lilly USA, LLC | 4 | $77 |
| ANI Pharmaceuticals, Inc. | 3 | $71 |
| Genentech USA, Inc. | 3 | $65 |
| AstraZeneca(2 entities) | 3 | $62 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| Novartis | 2 | $36 |
| Sanofi | 2 | $31 |
| Alvogen Inc | 1 | $30 |
| Zimmer Biomet | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Organon | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Fidia Pharma USA Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELARA$525
- SIMPONI ARIA$525
- Tremfya$525
- Rinvoq$240
How this compares
$3,228 in reported general payments places this provider in the 35th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 21 | $761 |
| MethotrexateMethotrexate Sodium | 30 | $593 |
| Prednisone | 30 | $301 |
| Alendronate Sodium | 30 | $234 |
| Duloxetine Hcl | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Lake Worth
- Juan Jose Maya VillamizarLake Worth$561K
- Martha Hernandez IllasFort Lauderdale$25M
- Carlos SesinMiami Beach$19M
- Guillermo ValenzuelaPlantation$14.2M
- Marimer Rensoli VelazquezMiami$12.2M
- Robert LevinClearwater$11M
- Jigar ShahMargate$5.6M
- Michael BubbGainesville$3.3M
- Vipul JoshiBrandon$3.1M
- Alvin WellsDestin$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.